SPRUCE BIOSCIENCES INC (SPRB) Stock Analyst Ratings
NASDAQ:SPRB - Nasdaq - US85209E1091 - Common Stock
ChartMill assigns a Buy % Consensus number of 51% to SPRB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.87. This target is 404.99% above the current price.
SPRB was analyzed by 11 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about SPRB.
In the last month the buy percentage fell by 24 points. So the trust of analysts is decreasing.
SPRB was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-12 | Guggenheim | Reiterate | Neutral -> Neutral |
| 2024-12-11 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-12-11 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-12-11 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-12 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-08-19 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-13 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-06-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-03-14 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-03-14 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2024-03-14 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-03-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-03-14 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-03-14 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-03-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-21 | Guggenheim | Initiate | Buy |
| 2023-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-13 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2023-08-18 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-16 | JMP Securities | Maintains | Outperform -> Outperform |
| 2023-08-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-23 | Oppenheimer | Reiterate | Outperform -> Outperform |